Send me a link:

*Text messaging rates may apply.

 Dow Up 0.12% Nasdaq Down 0.07%

Novavax, Inc. (NVAX)

-NasdaqGS
4.30 Down 0.11(2.39%) 3:36PM EDT - Nasdaq Real Time Price
Prev Close:4.40
Open:4.38
Bid:4.31 x 8400
Ask:4.32 x 4100
1y Target Est:11.00
Beta:1.17
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:4.18 - 4.39
52wk Range:2.24 - 6.95
Volume:1,590,441
Avg Vol (3m):4,069,190
Market Cap:898.68M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 2.39%898.68M
MRKDown 0.40%169.26B
NVSDown 0.67%213.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback